Substrate
science

Researchers Identify Neural Circuit Linking Spinal Cord and Brain in Chronic Pain

A study published in Nature details a neural circuit connecting the spinal cord, brain, and back to the spinal cord that contributes to chronic pain. The research used mouse models to map this pathway and test its role in pain persistence. Findings suggest potential targets for pain management therapies.

NA
1 source·Apr 7, 6:08 PM(28 days ago)·2m read
Researchers Identify Neural Circuit Linking Spinal Cord and Brain in Chronic PainSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
Audio version
Tap play to generate a narrated version.

Researchers have identified a specific neural circuit that links the spinal cord to the brain and back to the spinal cord, playing a role in the maintenance of chronic pain. The study, published in the journal Nature, focused on mouse models to deconstruct this pathway. The circuit involves projections from the spinal cord to the brain and returning signals that amplify pain signals over time.

The investigation mapped the spino-brain-spinal cord circuit using advanced imaging and genetic techniques. Sensory neurons in the spinal cord transmit initial pain signals to brain regions, including the parabrachial nucleus and insular cortex. From there, descending projections reinforce the pain response, leading to prolonged sensitivity.

dissect the circuit, the team employed optogenetics to activate or inhibit specific neurons.

Activation of the descending pathway in mice induced behaviors associated with ongoing pain, such as guarding and reduced activity. Inhibiting the circuit reduced pain hypersensitivity in models of inflammatory and neuropathic pain. The research highlighted the role of certain neuron types, including those expressing calcitonin gene-related peptide in the spinal cord.

These findings build on prior knowledge of ascending pain pathways but emphasize the bidirectional nature of the circuit in chronic conditions. The study was conducted by a team led by researchers at institutions including the University of Zurich and the Scripps Research Institute.

pain affects millions worldwide, often persisting after the initial injury heals.

This circuit's identification provides a anatomical basis for why pain becomes self-sustaining. Future research may explore pharmacological or neuromodulation approaches targeting this pathway. The study notes limitations, including its focus on rodent models, which may not fully translate to humans.

Clinical trials would be needed to validate these mechanisms in people. The paper, titled 'Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain,' was published on October 18, 2023. No direct quotes from the authors were highlighted in the source summary, but the work underscores the need for circuit-specific interventions in pain management.

Affected populations include those with conditions like arthritis, nerve damage, or post-surgical pain, where current treatments often fall short.

Key Facts

Spino-brain-spinal cord circuit
links spinal neurons to brain and back in pain persistence
Mouse models used
to activate and inhibit pathway with optogenetics
Inhibition effects
reduced hypersensitivity in inflammatory and neuropathic pain
Key brain regions
include parabrachial nucleus and insular cortex

Story Timeline

2 events
  1. October 18, 2023

    Nature publishes study on spino-brain-spinal cord circuit in chronic pain.

    1 source@Nature
  2. Prior to publication

    Researchers map and test neural circuit using mouse models and optogenetics.

    1 source@Nature

Potential Impact

  1. 01

    Identification of circuit may improve understanding of pain persistence mechanisms.

  2. 02

    Study may guide development of targeted drugs for chronic pain circuits.

  3. 03

    Findings could inform neuromodulation therapies for pain management.

  4. 04

    Research highlights need for human validation of rodent pain models.

Transparency Panel

Sources cross-referenced1
Confidence score70%
Synthesized bySubstrate AI
Word count353 words
PublishedApr 7, 2026, 6:08 PM
Bias signals removed2 across 1 outlet
Signal Breakdown
Loaded 1Editorializing 1

Related Stories

Hantavirus Cases Reported on MV Hondius Cruise Ship, Three Fatalities Amid Low Transmission Riskdeccanchronicle.com
science8 hrs agoDeveloping

Hantavirus Cases Reported on MV Hondius Cruise Ship, Three Fatalities Amid Low Transmission Risk

A hantavirus outbreak on the MV Hondius cruise ship has killed three passengers and sickened seven others, prompting an international response coordinated by the World Health Organization. The ship, carrying 147 people from 23 nationalities, is set to sail to Spain's Canary Islan…

Stat
Cbs News
2 sources
Imperial College London Study Analyzes Changes in Wildfire Weather Patterns in Northern Irelandtechjuice.pk
science2 hrs agoDeveloping

Imperial College London Study Analyzes Changes in Wildfire Weather Patterns in Northern Ireland

A new report from Imperial College London highlights growing wildfire threats in Northern Ireland due to more favorable conditions, especially in spring. Researchers note increased drought and fire-prone weather, exacerbated by climate change. The findings point to longer fire se…

The Bbc
1 source
FDA Commissioner Defends Drug Rejection DecisionsThe U.S. Food and Drug Administration / Wikimedia (Public domain)
science14 hrs agoFraming55Framing risk55/100Lede misdirection foregrounds commissioner's defense over substantive drug rejections; inherited negative valence from sources on agency turmoil and backlash.Click to jump to full framing analysis

FDA Commissioner Defends Drug Rejection Decisions

The FDA commissioner defended recent drug rejections in a CNBC interview, citing adherence to scientific reviews amid reports of agency turmoil. Criticism includes a high-profile denial of a melanoma treatment from Replimune and pressure from President Trump over vape approvals.…

cnbc.com
Wall Street Journal
joemygod.com
3 sources